Shiga Toxigenic E. Coli (stx1/2)

Bloody diarrhea can come from an infection that also puts your kidneys at risk. Certain E. coli strains carry genes for Shiga toxin and are called Shiga toxin-producing E. coli, or STEC. Finding these genes in stool can help identify the infection, but the result alone cannot show whether kidney injury has started or predict who will develop it.

Stool testing for these toxin genes is an established part of diagnosing suspected STEC infection. Interpreting a numerical bacterial estimate is a separate question. The studies supporting diagnosis and complication risk do not establish a CFU/g stool value that predicts how severe your illness will be.

What the Test Detects

This PCR test looks for stx1 and stx2 DNA in stool. Those genes contain the instructions for making Shiga toxin 1 and Shiga toxin 2. A positive combined stx1/2 result can mean that either gene, or both, were detected; it does not establish that both are present. Separate gene results or further strain testing are needed to tell them apart.

PCR stands for polymerase chain reaction. It copies a target stretch of DNA until there is enough to detect. That makes it possible to find toxin genes without first growing the bacteria, including genes from organisms that are no longer alive. The test detects the genetic instructions for toxin production, rather than measuring how much toxin is being released.

The catalog lists the reporting unit as CFU/g stool. CFU stands for colony-forming units, a measure normally obtained by growing live bacteria. With a PCR-based report, a number expressed in this unit depends on the laboratory's calibration of its DNA signal; it is not an observed count of growing colonies. The supplied metadata does not describe that calibration. Counts from different laboratories or methods should not be treated as interchangeable.

In many STEC strains, toxin genes are carried by viruses that infect bacteria. Shiga toxin interferes with protein production inside the cells it enters. It can damage the gut lining and the lining of small blood vessels, especially in the kidneys. Shiga toxin 1 closely resembles the toxin made by Shigella dysenteriae type 1. Shiga toxin 2 is a related toxin with several subtypes, some of which are strongly associated with severe disease.

Hemolytic Uremic Syndrome and Kidney Injury

The complication of greatest concern is hemolytic uremic syndrome, usually shortened to HUS. It combines red blood cell destruction, a falling platelet count, and sudden kidney injury. Young children are particularly vulnerable, though adults can develop severe disease too. HUS can appear several days into the illness, sometimes when the diarrhea is improving. Bloody diarrhea is a warning sign, but its absence does not rule out this complication.

Much of the evidence about toxin genes and HUS comes from identifying genes in bacteria cultured from stool. That research connects particular strains with outcomes; it does not validate a numerical risk prediction from this test's reported bacterial count.

A Finnish study examined children with culture-confirmed STEC infection between 2000 and 2016. Strains carrying stx2 were associated with about ten times the odds of HUS compared with strains without it. For stx2a, the corresponding association was about seventeenfold. Children younger than three also had higher odds of HUS. These are overlapping comparisons from one observational study, so the figures cannot be multiplied together or used as your personal probability of developing HUS.

In that study, toxin type did not predict major neurological complications or kidney outcome after HUS developed. The need for dialysis was associated with a worse kidney outcome. Once organ injury is present, the course of the illness and blood results provide information that the toxin gene result cannot replace.

Subtype matters within stx2. Among about 3,200 people with O157 infection in England from 2009 through 2019, strains carrying stx2a were more strongly associated with severe disease than strains carrying stx2c alone. Other bacterial genes and the infected person's characteristics also mattered. A combined stx1/2 result does not supply this subtype information.

In general, stx1-only infections have a lower risk of HUS than infections carrying certain stx2 subtypes. They can still cause serious illness. European surveillance has linked every reported Shiga toxin subtype to at least some severe cases, which is why symptoms and blood results remain part of the assessment even when a strain appears lower risk.

Bloody Diarrhea and Gut Inflammation

STEC can cause intense abdominal cramps and bloody diarrhea. In a Danish program that screened stool from about 30,000 people with suspected infectious diarrhea, stx1-only strains were less often associated with bloody diarrhea than strains carrying stx2. Swedish stool-screening research also linked stx2 with bloody diarrhea.

The eae gene provides additional information about a strain's ability to attach to the intestinal lining. Swedish research linked strains carrying both stx2 and eae with bloody diarrhea. But eae is not required for severe disease, and detecting two genes in a mixed stool sample does not by itself prove that the same bacterium carries both. Further characterization of an isolated strain can resolve that question.

The Danish study also associated stx1-only strains with prolonged digestive symptoms. That finding does not establish that the toxin caused lasting damage or that stx1 predicts symptoms after recovery. People selected for stool testing can differ in how long they have already been ill.

Health Problems Years Later

A Welsh study followed 1,245 people with confirmed O157 infection, including 65 who developed HUS, and compared them with people without a recorded infection. In primary care records, the infected group had almost twice the subsequent rate of kidney diagnoses. Digestive and respiratory diagnoses were also more frequent. The kidney estimate included people with HUS; it was not a separate estimate for uncomplicated infection.

The HUS subgroup had larger differences in several later health outcomes, though the estimates were uncertain because that group was small. This was an observational study of O157 infection. It cannot prove that infection caused every later diagnosis or establish the same risks for all non-O157 strains. It also provides no evidence that a higher stool PCR count predicts those outcomes.

Long-term kidney problems after STEC-associated HUS are better established. Follow-up studies have found high blood pressure, protein in the urine, or reduced kidney function years after the acute illness, including in some children who initially appeared to recover fully.

How PCR Differs From Culture and Toxin Testing

Traditional culture methods designed to find O157 use differences in how bacteria grow on selective plates. Most non-O157 STEC strains do not stand out on those plates. Modern laboratories may combine culture with a toxin or gene test, so what a 'routine stool culture' includes depends on the laboratory.

An immunoassay detects toxin protein. PCR detects the genes that encode it. Both can detect infections beyond O157, while growing and identifying an organism remains useful for confirming its identity and investigating outbreaks.

Published comparisons generally favor PCR for detecting STEC. The studies below evaluated other assays, sometimes after growing stool samples in broth. Their performance estimates cannot be assigned directly to this particular quantitative test.

A negative culture that only looked for O157 leaves other STEC strains unaddressed. A negative gene test is more informative about those strains, though collection timing, assay coverage, and sample quality still affect detection.

Shedding and Changes Over Time

Toxin genes can remain detectable after diarrhea stops. A Swedish study of children found a median of about 20 days of stx shedding after the first positive sample, with much longer periods in some children. A Finnish follow-up study found a similar median of about three weeks.

People can continue passing live bacteria in stool after they feel better. PCR can also detect DNA that does not come from live bacteria, so a positive result alone cannot establish how contagious you are. A falling CFU/g estimate has not been validated as proof that complications or transmission are no longer possible.

When Results Can Be Misleading

• Late collection or antibiotics: stool detection can become less reliable as the illness progresses or after antibiotic exposure. HUS may develop when stool testing is already negative. In that setting, specialist blood antibody testing can sometimes provide additional evidence of a preceding infection.
• Sample handling and PCR interference: substances in stool can interfere with DNA amplification. Improper collection or storage can also affect results. A negative result needs to be considered alongside symptoms and the laboratory's sample-quality checks.
• DNA without recoverable bacteria: PCR can detect DNA from nonviable organisms and, in some circumstances, free toxin-carrying bacterial viruses. A weak positive may fail to grow in culture, but that does not establish that it is harmless or that transmission is impossible.
• Genes shared by other bacteria: Shigella dysenteriae type 1 and occasional other organisms can carry related toxin genes. A toxin-gene result alone does not always identify the bacterial species. Culture or additional molecular testing may be needed.
• Assay coverage: PCR assays differ in the gene variants they recognize. Published evaluations have shown that some assays miss uncommon variants such as stx2f. The catalog metadata does not establish which rare variants this assay detects.
• Combined results and numerical counts: a combined stx1/2 result does not distinguish toxin types or subtypes. The reported count does not measure toxin activity, diagnose HUS, or determine whether you can return to food handling or childcare.